Tina Ventura
Chief Investor Relations Officer
Replay available
Madrigal Pharmaceuticals, Inc. (MDGL) Q1 2026 Earnings Call
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) Q1 2026 earnings conference call, held 2026-05-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Bill Sibyl
Chief Executive Officer
Dave Sorgel
Chief Medical Officer
Marty Deer
Chief Financial Officer
Prakhar Agarwal
Analyst, Kantar Pitiraltiskehet
Ash Verma
Analyst, UBS
Kripa Dwarakunda
Analyst, TruViz Securities
Yasmin Rahimi
Analyst, Piper Sandler
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Madrigal Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:01.893 Good morning, and thank you for standing by. 00:00:01.893 -- 00:00:07.541 Welcome to Madrigal Pharmaceuticals' first quarter 2026 earnings conference call. 00:00:07.541 -- 00:00:10.685 At this time, all participants are in a listen-only mode. 00:00:10.685 -- 00:00:14.690 After the speaker's presentation, there will be a question-and-answer session. 00:00:14.690 -- 00:00:18.094 As a reminder, today's conference call is being recorded. 00:00:18.094 -- 00:00:23.842 I would now like to introduce Ms. Tina Ventura, Chief Investor Relations Officer. 00:00:23.842 -- 00:00:25.724 Please go ahead. 00:00:25.724 -- 00:00:30.144 Thanks, Brula. Good morning, everyone, and thank you for joining us to discuss Madrigal's 00:00:30.144 -- 00:00:32.887 first quarter 2026 earnings. 00:00:32.887 -- 00:00:37.553 We issued a press release this morning and posted a slide deck to accompany this webcast 00:00:37.553 -- 00:00:41.215 on the Investor Relations section of our website. 00:00:41.297 -- 00:00:45.722 On the call with me today is Bill Sibyl, Chief Executive Officer, Dave Sorgel, Chief 00:00:45.722 -- 00:00:49.306 Medical Officer, and Marty Deer, Chief Financial Officer. 00:00:49.306 -- 00:00:53.204 They will provide prepared remarks, followed by Q&A. 00:00:53.204 -- 00:00:57.913 Please note on slide two, we will be making certain forward-looking statements today. 00:00:57.913 -- 00:01:03.302 We refer you to our SEC filings for a discussion of the risks that may cause actual results 00:01:03.302 -- 00:01:06.148 to differ from the forward-looking statements. 00:01:06.148 -- 00:01:09.594 With that, I will now turn the call over to Bill on slide three. 00:01:09.594 -- 00:01:12.018 Thanks, Tina. Good morning and thanks for joining us. 00:01:12.018 -- 00:0...